Universität zu Köln

Journal Article

Waldschmidt, D., El-Khoueir, A. B., Kim, R. D., Harris, W. P., Sung, M. W., Iqbal, S., Zhang, A., Nakajima, K. and Galle, P. R. (2020). Phase 1b study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). Oncol. Res. Treat., 43 (SUPPL 4). S. 123 - 124. BASEL: KARGER. ISSN 2296-5262